Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice

Hormones and Behavior
Chul Ju HwangJ Hong

Abstract

Approximately, 7-10 million people in the world suffer from Parkinson's disease (PD). Recently, increasing evidence has suggested the protective effect of estrogens against nigrostriatal dopaminergic damage in PD. In this study, we investigated whether estrogen affects 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced behavioral impairment in estrogen receptor alpha (ERα)-deficient mice. MPTP (15mg/kg, four times with 1.5-h interval)-induced dopaminergic neurodegeneration was evaluated in ERα wild-type (WT) and knockout (KO) mice. Larger dopamine depletion, behavioral impairments (Rotarod test, Pole test, and Gait test), activation of microglia and astrocytes, and neuroinflammation after MPTP injection were observed in ERα KO mice compared to those in WT mice. Immunostaining for tyrosine hydroxylase (TH) after MPTP injection showed fewer TH-positive neurons in ERα KO mice than WT mice. Levels of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC, metabolite of dopamine) were also lowered in ERα KO mice after MPTP injection. Interestingly, a higher immunoreactivity for monoamine oxidase (MAO) B was found in the substantia nigra and striatum of ERα KO mice after MPTP injection. We also found an increased activation of p...Continue Reading

References

Jan 1, 1991·Free Radical Biology & Medicine·J D Adams, I N Odunze
Oct 1, 1990·Italian Journal of Neurological Sciences·M Onofrj, M F Ghilardi
Oct 1, 1988·Neurology·J F Kurtzke, I D Goldberg
May 16, 1985·Biochemical and Biophysical Research Communications·K ChibaN Castagnoli
Apr 30, 1984·Biochemical and Biophysical Research Communications·K ChibaN Castagnoli
Oct 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P LevittX O Breakefield
Jan 1, 1994·Reviews in the Neurosciences·T Di Paolo
Jun 1, 1993·Glia·J EkblomS M Aquilonius
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Sep 1, 1996·Neurotoxicology and Teratology·D E DluzenB Liu
Dec 1, 1996·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·D C GermanP K Sonsalla
Jul 21, 1998·Annals of the New York Academy of Sciences·D B MillerS C Laws
Aug 11, 1998·Life Sciences·D P HolschneiderJ C Shih
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·A HartmannE C Hirsch
Apr 25, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P D Hurn, I M Macrae
Oct 3, 2000·Endocrinology·A J Bruce-KellerM P Mattson
Feb 13, 2001·The Journal of Steroid Biochemistry and Molecular Biology·P J KushnerP Webb
Mar 15, 2001·Parkinsonism & Related Disorders·R H. SwerdlowG F. Wooten
May 10, 2001·Proceedings of the National Academy of Sciences of the United States of America·G S De Zutter, R J Davis
Jan 10, 2002·Journal of Clinical Epidemiology·Alexis ElbazWalter A Rocca
Mar 14, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Rocio SanchezSylvie Mader
Jul 20, 2002·Trends in Endocrinology and Metabolism : TEM·Phyllis M Wise
Oct 23, 2002·Biology of Reproduction·Krishnan M Dhandapani, Darrell W Brann
May 22, 2003·Neuroscience Letters·Aristea S GalanopoulouJana Velísková
Jun 5, 2003·American Journal of Epidemiology·Stephen K Van Den EedenLorene M Nelson
Feb 21, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kathleen NewhouseZhengui Xia
Mar 17, 2004·Brain Research·Joanne R MathiasenDonna Bozyczko-Coyne
Dec 8, 2004·Experimental Gerontology·C D Toran-Allerand
Feb 8, 2005·Molecular Endocrinology·Linda Björnström, Maria Sjöberg
Feb 19, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Robert M SilvaRobert E Burke

❮ Previous
Next ❯

Citations

Nov 27, 2018·Translational Neuroscience·Jianying HeWeiyan Hu
Feb 6, 2020·Oxidative Medicine and Cellular Longevity·Perla Ugalde-MuñizAnahí Chavarría

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.